EP0474676A4 - Production of ibdv vp2 in highly immunogenic form - Google Patents

Production of ibdv vp2 in highly immunogenic form

Info

Publication number
EP0474676A4
EP0474676A4 EP19900908160 EP90908160A EP0474676A4 EP 0474676 A4 EP0474676 A4 EP 0474676A4 EP 19900908160 EP19900908160 EP 19900908160 EP 90908160 A EP90908160 A EP 90908160A EP 0474676 A4 EP0474676 A4 EP 0474676A4
Authority
EP
European Patent Office
Prior art keywords
ibdv
production
highly immunogenic
immunogenic form
highly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900908160
Other versions
EP0474676A1 (en
Inventor
Ahmed Abdulla Azad
Ian Geoffrey Macreadie
Neil Moreton Mckern
Paul Richard Vaughan
Mittur Nanjappa Jagadish
Kevin John Fahey
Antony James Chapman
Hans-Georg Heine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of EP0474676A1 publication Critical patent/EP0474676A1/en
Publication of EP0474676A4 publication Critical patent/EP0474676A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
EP19900908160 1989-05-30 1990-05-29 Production of ibdv vp2 in highly immunogenic form Withdrawn EP0474676A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU4469/89 1989-05-30
AUPJ446989 1989-05-30
AU57315/90A AU643216B2 (en) 1989-05-30 1990-05-29 Production of IBDV VP2 in highly immunogenic form

Publications (2)

Publication Number Publication Date
EP0474676A1 EP0474676A1 (en) 1992-03-18
EP0474676A4 true EP0474676A4 (en) 1993-02-24

Family

ID=25631592

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900908160 Withdrawn EP0474676A4 (en) 1989-05-30 1990-05-29 Production of ibdv vp2 in highly immunogenic form

Country Status (3)

Country Link
EP (1) EP0474676A4 (en)
AU (1) AU643216B2 (en)
WO (1) WO1990015140A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016925A1 (en) * 1990-05-04 1991-11-14 University Of Maryland At College Park Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
BE1004877A3 (en) * 1991-05-27 1993-02-16 Solvay RECOMBINANT AVIPOX VIRUS, CULTURE OF CELLS INFECTED WITH THIS VIRUS AND POULTRY VACCINES DERIVED FROM THIS VIRUS.
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
FR2751225B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux AVIAN POLYNUCLEOTIDE VACCINE FORMULA
WO2001092486A1 (en) * 2000-05-31 2001-12-06 Akzo Nobel N.V. Serotype chimeric ibdv strains
AUPR546801A0 (en) * 2001-06-05 2001-06-28 Commonwealth Scientific And Industrial Research Organisation Recombinant antibodies
ES2417019T3 (en) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Characterization procedure of infectious bursitis disease virus
DE102011121069A1 (en) * 2011-12-13 2013-06-13 Martin-Luther-Universität Halle-Wittenberg Vaccination by recombinant yeast by generating a protective humoral immune response against defined antigens
CN114276420A (en) * 2021-10-28 2022-04-05 华南农业大学 Soluble VP2 antigen, vaccine and preparation method of antigen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587624B2 (en) * 1985-05-30 1989-08-24 Commonwealth Scientific And Industrial Research Organisation Expression of host-protective immunogens of ibdv.
AU619477B2 (en) * 1987-06-26 1992-01-30 Commonwealth Scientific And Industrial Research Organisation Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF GENERAL VIROLOGY, vol. 70, 1989, GB; K.J. FAHEY et al., pp. 1473-1481 *
JOURNAL OF GENERAL VIROLOGY, vol. 71, 1990; F.S.B. KIBENGE et al., pp. 569-577 *
JOURNAL OF THE CHINESE SOCIETY OF VET. SCIENCE, vol. 13, 1987; L.H. LEE et al., pp. 99-108 *
See also references of WO9015140A1 *
VIROLOGY, vol. 143, 1985; A.A. AZAD et al., pp. 35-44 *
VIROLOGY, vol. 161, 1987; A.A. AZAD et al., pp. 145-152 *

Also Published As

Publication number Publication date
AU643216B2 (en) 1993-11-11
EP0474676A1 (en) 1992-03-18
WO1990015140A1 (en) 1990-12-13
AU5731590A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
GB2189150B (en) Prosthesis and process for its manufacture
ZA852724B (en) Multivalent pneumococcal vaccine and preparation thereof
GB8924438D0 (en) Vaccine composition
EP0406440A4 (en) Production of polyether
EP0256561A3 (en) Sweet and process for its preparation
ZA90474B (en) Vaccine composition
IL90312A (en) Preparation of perfluoropolyethers
GR890100817A (en) Purfines preparation process
IL96306A0 (en) Preparation of deoxyfluoronucleosides
EP0474676A4 (en) Production of ibdv vp2 in highly immunogenic form
GB2194155B (en) Improvements in prostheses
LTIP1406A (en) Edulcorant and its preparation process
EP0245835A3 (en) Novel thiophene derivatives and methods for producing the same
IL85944A0 (en) 5-pyrazinyl-1,3,4-oxadiazole and thia-diazole derivatives their preparation and their use as nematicides
AP9000165A0 (en) Vaccine composition
ZA876598B (en) Bromofluoroethylhypofluorite and process for its preparation
IL81920A0 (en) Vaccines and their preparation
GB2234254B (en) Methylpolysilanes having controllable rheology and method for their preparation
EP0408332A3 (en) Natural fermentation agent
GB2248186B (en) Preparation of vaccines
GB8711988D0 (en) Combined sequencer & inserter machine
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GB2187737B (en) Preparation of 2,6-dihalo-4-cyanophenol esters
HU204708B (en) Process for producing tea blend having high consumption value and medicinal effect
GB8918394D0 (en) Preparation of polyhemiacetals

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910919

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930108

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19931201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980610